These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22721881)

  • 1. Confirmation of a proarrhythmic risk underlying the clinical use of common Chinese herbal intravenous injections.
    Chen L; Titch T; Luo Z; Xu Y; Li X; Huang F; Liu L; Xiao W; Wu H; Wang Z
    J Ethnopharmacol; 2012 Aug; 142(3):829-35. PubMed ID: 22721881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic Studies on the Risks and Potential Mechanism Underlying the Proarrhythmic Nature of Azithromycin.
    Zhang M; Xie M; Li S; Gao Y; Xue S; Huang H; Chen K; Liu F; Chen L
    Cardiovasc Toxicol; 2017 Oct; 17(4):434-440. PubMed ID: 28213753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
    Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
    J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iloperidone (Fanapt®), a novel atypical antipsychotic, is a potent HERG blocker and delays cardiac ventricular repolarization at clinically relevant concentration.
    Vigneault P; Pilote S; Patoine D; Simard C; Drolet B
    Pharmacol Res; 2012 Jul; 66(1):60-5. PubMed ID: 22465688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin2 prolongs action potential duration and modulates potassium currents in guinea pig myocytes and HEK293 cells.
    Yang LZ; Zhu YC
    Eur J Pharmacol; 2015 Jul; 758():97-106. PubMed ID: 25863256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological safety of sibutramine HCl.
    Kim KS; Park SJ; Lee HA; Kim DK; Kim EJ
    Hum Exp Toxicol; 2008 Jul; 27(7):553-8. PubMed ID: 18829731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
    Crumb WJ; Vicente J; Johannesen L; Strauss DG
    J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QTc shortening with a new investigational cancer drug: a brief case study.
    Himmel HM; Hoffmann M
    J Pharmacol Toxicol Methods; 2010; 62(1):72-81. PubMed ID: 20570746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba extract and ginkgolide antiarrhythmic potential by targeting hERG and ICa-L channel.
    Zhao X; Yao H; Yin HL; Zhu QL; Sun JL; Ma W; Shi YQ; Liang ZG; Li BX
    J Pharmacol Sci; 2013; 123(4):318-27. PubMed ID: 24225402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute alteration of cardiac ECG, action potential, I(Kr) and the human ether-a-go-go-related gene (hERG) K+ channel by PCB 126 and PCB 77.
    Park MH; Park WS; Jo SH
    Toxicol Appl Pharmacol; 2012 Jul; 262(1):60-9. PubMed ID: 22676973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.
    Rubi L; Kovar M; Zebedin-Brandl E; Koenig X; Dominguez-Rodriguez M; Todt H; Kubista H; Boehm S; Hilber K
    Toxicol Appl Pharmacol; 2017 Aug; 329():309-317. PubMed ID: 28641963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
    Qu Y; Gao B; Fang M; Vargas HM
    J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrophysiological effect of cannabidiol on hERG current and in guinea-pig and rabbit cardiac preparations.
    Orvos P; Pászti B; Topal L; Gazdag P; Prorok J; Polyák A; Kiss T; Tóth-Molnár E; Csupor-Löffler B; Bajtel Á; Varró A; Hohmann J; Virág L; Csupor D
    Sci Rep; 2020 Sep; 10(1):16079. PubMed ID: 32999428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the effects of urinary incontinence agents S-oxybutynin and terodiline on cardiac K(+) currents and action potentials.
    Jones SE; Shuba LM; Zhabyeyev P; McCullough JR; McDonald TF
    Br J Pharmacol; 2000 Sep; 131(2):245-54. PubMed ID: 10991917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
    Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.